Health Press Release – Weekly Newsletter for January 17-24, 2011

MRC Technology Appoints New Director of Corporate Partnerships

LONDON, January 17, 2011 – MRC Technology announced today that Mike Johnson has been appointed
Director, Corporate Partnerships. Mike joins MRC Technology to act as the
principal conduit for communication between the UK's Medical Research Council
(MRC) and MRC Technology, and to build productive partnerships with
technology and funding organisations both nationally and internationally
while ensuring operational delivery of …. Original article on Gaea Times at  : MRC Technology Appoints New Director of Corporate Partnerships.

Chiltern Wins Multiple Pharma Awards at the Prestigious Annual PharmaTimes Awards Ceremony

LONDON, January 17, 2011 – Chiltern International Limited (Chiltern), a global contract research
organization (CRO), announced that Chiltern has won multiple awards at the
PharmaTimes Annual Awards 2010 ceremony held at the Park Plaza Riverbank
Hotel in London. The competition, established in 1999, celebrates the
competence and ability of top clinical research professionals.

Glenn Kerkhof, …. Original article  : Chiltern Wins Multiple Pharma Awards at the Prestigious Annual PharmaTimes Awards Ceremony.

Astellas Enters Into License Agreement With TOLMAR

Expansion of Territory for Eligard(R) in Asia, Middle East, Africa and CIS
TOKYO, January 17, 2011 – Astellas Pharma Inc. (TSE:4503"Astellas") announced today that its
European subsidiary Astellas Pharma Europe Ltd.("Astellas Pharma Europe",
headquarters: Stains, U.K.)" acquired the license for commercialization of
the treatment for advanced prostate cancer Eligard(R) from TOLMAR Inc.
("TOLMAR", headquarters: Colorado, U.S.A.) on December 22, … Read this article on Gaea Times at : Astellas Enters Into License Agreement With TOLMAR.

Final NICE Appraisal Recommends Improved Access to Treatment and Care of People With Early Alzheimer’s Disease

New Survey Shows More Than Half (57.9%) of GPs Likely to Recall Mild Alzheimer's Patients Previously Denied Treatment for Reassessment

LONDON, January 18, 2011 – The National Institute for Health and Clinical Excellence (NICE) today
published its final appraisal determination containing final recommendations
on the use of specific treatments for Alzheimer's disease. The new ruling
means Alzheimer's patients …. Source  : Final NICE Appraisal Recommends Improved Access to Treatment and Care of People With Early Alzheimer's Disease.

Glasgow Eye Students Make it a First

GLASGOW, Scotland, January 18, 2011 – Optometry and Dispensing Optician students at Glasgow Caledonian
University received a massive boost, becoming the first in Scotland to
benefit from state of the art eye diagnostic technology following a donation
from Optical Express.

The Oculus Pentacam, which offers a precise analysis of the eye, was
given to the … Read more : Glasgow Eye Students Make it a First.

Ingenuity Systems and Erasmus University Medical Center Collaborate on Next-Generation Sequencing Project to Accelerate Disease Research

IPA(R) used to identify and prioritize novel causal variant
REDWOOD CITY, California, January 18, 2011 – Ingenuity(R) Systems, a leading provider of information solutions for
life science researchers, and Erasmus Medical Center, jointly announced a
scientific collaboration using next-generation sequencing (NGS) for disease
research.

As part of the collaboration, Erasmus researchers have been working
closely with …. Source article on Gaea Times at  : Ingenuity Systems and Erasmus University Medical Center Collaborate on Next-Generation Sequencing Project to Accelerate Disease Research.

Great Ormond Street Hospital the Winner in Battle of the Celebrities Between Morgan and Sugar

LONDON, January 18, 2011 – Great Ormond Street Hospital in London benefited from a charitable
donation after Piers Morgan and Alan Sugar donned their boxing gloves in a
battle to collect the most followers on Twitter by Christmas.

The recent 'tweet off' between the two stars set the scene for an
interesting challenge to … Original source on Gaea Times at : Great Ormond Street Hospital the Winner in Battle of the Celebrities Between Morgan and Sugar.

Co-Promotion of a New Medical Device for Female Infertility Announced

SPARTANBURG, South Carolina, January 18, 2011 – Norgenix Pharmaceuticals, LLC (www.norgenixpharma.com), a wholly
owned subsidiary of Spartanburg-based J M Smith Corporation, and Fertility
Focus Limited (www.fertility-focus.com) today announced a partnership
for the co-promotion of the Fertiloscope(TM), a CE marked and 510(k) approved
surgical instrument for the early diagnosis and immediate corrective surgery
of physical causes of female infertility. Norgenix … Original source on Gaea Times at : Co-Promotion of a New Medical Device for Female Infertility Announced.

Alzheimer’s Foundation International Forms Alzheimer’s Foundation of Israel

Israel's Leading Care Organization Signs on as Founding Member
NEW YORK, January 18, 2011 – The Alzheimer's Foundation International (AFI) today announced the
ground-breaking formation of the Alzheimer's Foundation of Israel, with
Melabev, Israel's leading organization caring for individuals with
Alzheimer's disease, as one of the founding members of the new organization.

AFI is an … Read the original article on Gaea Times at : Alzheimer's Foundation International Forms Alzheimer's Foundation of Israel.

Digital Display System Specialist Jayex Launches Med-Extranet Online Media Library

Jayex Enables Healthcare Organisations to Educate Patients Through Med-Extranet Material Displayed on Waiting Room Screens

LONDON, January 19, 2011 – www.jayex.com, the healthcare digital display system
(www.jayex.com/digital-display-system.html) specialist, today
announces the launch of Med-Extranet (www.jayex.com/Med-Extranet.html
); its online healthcare media library. Med-Extranet offers hospitals,
clinics, and GP surgeries online access to educational videos, digital
posters and public service announcements that … Original source on Gaea Times at : Digital Display System Specialist Jayex Launches Med-Extranet Online Media Library.

Elsevier Announces New Editor-in-Chief for Neurobiology of Learning and Memory

NEW YORK, January 19, 2011 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and solutions, is pleased to announce that Professor
John F. Guzowski of University of California, Irvine, has accepted the
position of Editor-in-Chief of Neurobiology of Learning and Memory
(www.elsevier.com/wps/find/journaldescription.cws_home/622924/descript
ion#description). He succeeds Professor Paul E. Gold of University of
Illinois at Urbana-Champaign from …. Source article  : Elsevier Announces New Editor-in-Chief for Neurobiology of Learning and Memory.

Novo Nordisk’s New Pen for Children – NovoPen Echo(R) – Wins GOOD DESIGN(TM) Award

CRAWLEY, England, January 19, 2011 – A 2010 GOOD DESIGN(TM) Award[1] has been awarded to Novo Nordisk for
NovoPen Echo(R), the latest innovation in pen development – designed
specifically with the needs of children in mind. Judging is made based on
product design which is new, visionary and innovative and that may enrich
people's lives.

… Read more : Novo Nordisk's New Pen for Children – NovoPen Echo(R) – Wins GOOD DESIGN(TM) Award.

International Society for Cellular Therapy (ISCT) Launches Inaugural Cell Therapy Commercial Development Focus Group on Peripheral Vascular Disease

VANCOUVER, January 19, 2011 – In keeping with its commitment to connect industry, regulatory experts,
therapeutic societies and translational centers to advance emerging cellular
therapies, ISCT announces its first commercial development focus group
addressing Cell Therapies for Peripheral Vascular Disease (PVD).

PVD is a condition in which the arteries that carry blood to the … Read more : International Society for Cellular Therapy (ISCT) Launches Inaugural Cell Therapy Commercial Development Focus Group on Peripheral Vascular Disease.

Elekta Receives CE Mark for Fraxion, Immobilization System Designed to Improve Accuracy and Precision in Cranial Cancer Treatments

CRAWLEY, England, January 19, 2011 – Elekta has received CE mark clearance for its Fraxion(TM)
patient-specific cranial immobilization system. The Fraxion head frame helps
ensure accuracy and precision in stereotactic radiation therapy of cancer
targets in the brain and cranium. Elekta's Fraxion is the first to introduce
an innovative system that integrates all proven cranial immobilization
options in a …. Original article on Gaea Times at  : Elekta Receives CE Mark for Fraxion, Immobilization System Designed to Improve Accuracy and Precision in Cranial Cancer Treatments.

Oncos Therapeutics Appoints Dr. Jonathan Knowles and Dr. Robert Burns to the Board of Directors

HELSINKI, January 20, 2011 – Oncos Therapeutics, a biotech company developing novel cancer
therapeutics based on its next generation oncolytic viruses, announced today
the appointments of Dr. Jonathan Knowles and Dr. Robert Burns to the Board of
Directors.

"This is one of the most interesting new approaches to cure
cancer. The anti-tumor immune response induced …. Source article  : Oncos Therapeutics Appoints Dr. Jonathan Knowles and Dr. Robert Burns to the Board of Directors.

MarketsandMarkets: Top 10 Drug Delivery Technologies Market to be US$156 Billion by 2015

DALLAS, January 20, 2011 – The 'Top 10 Drug Delivery Technologies Market (2010 – 2015)' analyzes the
drug delivery technologies market by the top 10 drug delivery technologies
and studies the major market drivers, restraints, and opportunities in North
America, Europe, Asia and ROW.

Browse 75 market data tables and in-depth TOC on Top … Read more : MarketsandMarkets: Top 10 Drug Delivery Technologies Market to be US$156 Billion by 2015.

Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance

Cognizant's Next-Generation "Business Process as a Service" Model to Provide Lilly USA Greater Flexibility and Predictability

TEANECK, New Jersey, January 20, 2011 – Cognizant (Nasdaq: CTSH), a leading provider of consulting, technology,
and business process outsourcing (BPO) services, announced that it has been
selected by Eli Lilly and Company, one the world's leading innovation-driven
pharmaceutical companies, to deliver …. Source  : Cognizant Selected by Lilly to Deliver Commercial Operations Solutions to Enhance Sales and Marketing Effectiveness, Business Performance.

European Research Council Selects Elsevier’s SciVerse Scopus Database

Funding Body Will Use Publications and Citations Data to Track Success of Funded Projects

AMSTERDAM, January 20, 2011 – Elsevier's SciVerse Scopus (www.info.sciverse.com/scopus/)
database was selected by the European Research Council (ERC) to assist in the
tracking and awarding of funding opportunities for researchers throughout the
world. The ERC, the European funding body managing the 'Ideas Programme of
the … Read more >>>.

Bupa Care Homes to Host Storytelling Week Events

LONDON, January 20, 2011 – Bupa Care Homes in Yorkshire are preparing to enjoy a number of
storytelling events in support of National Storytelling Week (29 January to 5
February 2011).

This year, Bupa has teamed up with charity The Reader Organisation, which
has been working with care homes (
www.bupa.co.uk/individuals/care-homes) since 2006, promoting the …. Source article  : Bupa Care Homes to Host Storytelling Week Events.

InformexUSA 2011 Projects Record Attendance

Exhibitor and registration numbers reflect growing market confidence
PRINCETON, New Jersey, January 20, 2011 – Informex (www.informex.com), the leading meeting place for buyers
and sellers of high-value chemistry for a broad range of applications, today
announced projections that 2011 will be a record setting year for both
attendee and exhibitor numbers at the brand's flagship event, InformexUSA
(February 7-10, … Read the original article on Gaea Times at : InformexUSA 2011 Projects Record Attendance.

Study Suggests Urine NGAL Biomarker May Help Predict Delayed Graft Function

DELKENHEIM, Germany, January 20, 2011 – A diagnostic test for early detection of acute kidney injury may assist
in predicting delayed graft function (DGF) in kidney transplant patients,
according to a Finnish study published in Kidney International, the journal
of the International Society of Nephrology.

DGF occurs when a transplanted kidney does not function … Read : Study Suggests Urine NGAL Biomarker May Help Predict Delayed Graft Function.

Abbott’s XIENCE PRIME(TM) Receives CE Mark for Treatment of Most Advanced Form of Arterial Disease in the Lower Leg

Positive Results of DESTINY Trial Supported CE Mark for XIENCE PRIME for the Treatment of Critical Limb Ischemia or Severe Claudication (Pain) of the Lower Leg

BRUSSELS, January 20, 2011 – Abbott announced today that it has received CE Mark for its XIENCE
PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of
critical limb ischemia (CLI) …. Original article  : Abbott's XIENCE PRIME(TM) Receives CE Mark for Treatment of Most Advanced Form of Arterial Disease in the Lower Leg.

Disciplinary Committee Suspends Former Southampton Vet

LONDON, January 20, 2011 – The Disciplinary Committee of the Royal College of Veterinary Surgeons
has this week suspended from the RCVS Register a veterinary surgeon formerly
practising in Southampton for failing to make animal welfare his primary
concern.

At a hearing this week [17/18 January] adjourned from September 2010, the
Disciplinary Committee heard charges …. Read the original article  : Disciplinary Committee Suspends Former Southampton Vet.